Document is current
Any future updates will be listed below
-
Authors
Pallaseni, Ananth https://orcid.org/0000-0002-4840-195X
Peets, Elin Madli https://orcid.org/0000-0002-3479-1969
Girling, Gareth
Crepaldi, Luca
Kuzmin, Ivan
Moor, Marilin
Muñoz-Subirana, Núria
Schimmel, Joost
Serçin, Özdemirhan
Mardin, Balca R.
Tijsterman, Marcel https://orcid.org/0000-0001-8465-9002
Peterson, Hedi
Kosicki, Michael
Parts, Leopold https://orcid.org/0000-0002-2618-670X
-
Funding
Funding for this research was provided by:
Wellcome Trust (220540/Z/20/A)
Wellcome
NIH
Estonian Research Council
Dutch Cancer Society
HollandPTC-Varian
- License Information
-
More Information
Article History
Received: 16 June 2023
Accepted: 15 November 2024
First Online: 27 November 2024
Competing interests
: B.M. is an employee of Merck Healthcare, Darmstadt, Germany. O.S. is an employee of BioMed X Institute (GmbH), Heidelberg, Germany, which receives research grants from Merck KGaA. L.P. Receives remuneration and stock options from ExpressionEdits. The remaining authors declare no competing interests.
